Selinexor

FDA sets back Karyopharm's bid to broaden use of cancer drug
BioPharma Dive
Wed, 03/2/22 - 12:08 pm
Karyopharm Therapeutics
Selinexor
clinical trials
FDA
cancer
Karyopharm drug tested in ‘industry-first’ approach to brain cancer
Pharmaforum
Fri, 07/12/19 - 12:05 pm
Karyopharm
Xpovio
brain cancer
Selinexor
clinical trials
glioblastoma
Karyopharm’s Xpovio nabs myeloma nod despite checkered past. But 5th line?
Fierce Pharma
Mon, 07/8/19 - 08:07 pm
Karyopharm
FDA
Multiple Myeloma
Xpovio
Selinexor
After negative panel vote, FDA approves Karyopharm's multiple myeloma drug
BioCentury
Fri, 07/5/19 - 01:36 pm
Karyopharma
Xpovio
Selinexor
FDA
Multiple Myeloma
FDA Action Alert: Karyopharm, Merck and Celgene
BioSpace
Mon, 07/1/19 - 10:54 pm
FDA
Karyopharm
Selinexor
Merck
relebactam
Celgene
Otezla
Mass exodus of Amgen sales reps sparks legal battle with multiple myeloma rival Karyopharm
Fierce Pharma
Fri, 05/24/19 - 04:35 pm
Amgen
sales poaching
drug reps
Karyopharm Therapeutics
Multiple Myeloma
Selinexor
Karyopharm gets bump as FDA extends review of selinexor
BioCentury
Fri, 03/15/19 - 10:42 am
Karyopharm
FDA
Selinexor
Multiple Myeloma
ODAC backs delay for Karyopharm’s selinexor
BioCentury
Tue, 02/26/19 - 11:43 pm
Karyopharm Therapeutics
ODAC
Selinexor
Karyopharm down as FDA reviewers cast doubt on selinexor's benefit
BioCentury
Sat, 02/23/19 - 04:35 pm
Karyopharm Therapeutics
FDA
Selinexor
Multiple Myeloma
Karyopharm to pursue FDA approval for multiple myeloma drug based on new study results
Stat
Mon, 04/30/18 - 07:33 pm
Karyopharm Therapeutics
FDA
Multiple Myeloma
Selinexor
clinical trials
Karyopharm bags a $193M Asian deal for selinexor and followup drug, shares jump
Endpoints
Thu, 10/12/17 - 09:29 am
Karyopharm
Selinexor
Ono
Karyopharm shakes off clinical hold for lead cancer med
BioPharma Dive
Fri, 03/31/17 - 11:00 am
Karyopharm
Selinexor
clinical trials
solid tumors
diffuse large B-cell lymphoma
Multiple Myeloma
FDA orders Karyopharm to halt enrollment for all selinexor trials, citing incomplete safety warning
Endpoints
Sun, 03/12/17 - 10:50 am
Karyopharm
Selinexor
clinical trials
FDA
Karyopharm sets a course for the FDA with positive PhIIb multiple myeloma data
Endpoints
Tue, 09/6/16 - 10:56 am
Karyopharm
FDA
clinical trials
Multiple Myeloma
Selinexor
3 Clinical-Stage Biotech Stocks With News About To Break
Motley Fool
Thu, 09/1/16 - 09:30 am
Novavax
RSV F vaccine
Agile Therapeutics
birth control patch
Twirla
Karyopharm
Selinexor
Multiple Myeloma
GlycoMimetics, Karyopharm ride the wave of new biotech IPOs
Fierce Biotech
Mon, 10/7/13 - 09:00 am
IPOs
GlycoMimetics
Karyopharm
Selinexor
cancer
GMI-1070
sickle cell disease